TrialBMC infectious diseases2017

Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study.

Edward J Gane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.